Source: Annual Congress 2005 - Treatment of pulmonary and extrapulmonary tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. Cimen Ozisik, Z. Arslan, B. Tuzun, S. Sarac, O. Oruc, G. Yurteri (Istanbul, Turkey). Effect on treatment of giving information about tuberculosis to the tuberculosis patients. Eur Respir J 2005; 26: Suppl. 49, 4083

Member's Comments

No comment yet.

Related content which might interest you: Knowledge of tuberculosis patients about tuberculosis and importance of this Source: Eur Respir J 2004; 24: Suppl. 48, 195s Year: 2004 Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008 Rimfampicin importance in tuberculosis treatment Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008 The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses Source: Eur Respir J 2001; 18: Suppl. 33, 473s Year: 2001 Effects of complex treatment with izofon of a pulmonary tuberculosis in children Source: Eur Respir J 2004; 24: Suppl. 48, 652s Year: 2004 Influence of social adaptation of tuberculosis patients on the TB form and a chemotherapy outcomes Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012 Comparison of two different cohorts of patients for multidrug-resistant tuberculosis treatment evaluation Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB) Year: 2006 Different genetics background of patients with latent tuberculosis infection versus active tuberculosis Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017 Knowledge of tuberculosis patients about tuberculosis disease Source: Eur Respir J 2006; 28: Suppl. 50, 19s Year: 2006 Profiles of tuberculosis disease activation among contacts of patients with tuberculosis Source: Eur Respir J, 54 (4) 1900353; 10.1183/13993003.00353-2019 Year: 2019 Changes in the metabolism of Mycobacterium tuberculosis during the course of TB treatment Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021 Hair-analysis for acetyl-isoniazid/isoniazid ratio and N-acetyl-transferase-2-genotype in patients on treatment for mycobacterium tuberculosis infection Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2016; 47:1592-1594 Year: 2016 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2016; 47:1594-1595 Year: 2016 Benefit of treatment of latent tuberculosis infection in individual patients Source: Eur Respir J 2015; 46: 1397-1406 Year: 2015 The definition of tuberculosis infection based on the spectrum of tuberculosis disease Source: Breathe, 17 (3) 210079; 10.1183/20734735.0079-2021 Year: 2021 Management of multidrug-resistant tuberculosis and patients in retreatment Source: Eur Respir J 2005; 25: 928-936 Year: 2005 Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012 Results of drug susceptibility testing of Mycobacterium tuberculosis isolated from sputum and surgical material from pulmonary tuberculosis patients Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 The tuberculosis patients’ perspective Source: Eur Respir Monogr 2018; 82: 1-7 Year: 2018